Rankings
▼
Calendar
INSM Q4 2025 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena
INSM
Insmed Incorporated
$31B
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$264M
+152.6% YoY
Gross Profit
$218M
82.5% margin
Operating Income
-$250M
-94.6% margin
Net Income
-$328M
-124.5% margin
EPS (Diluted)
$-1.54
QoQ Revenue Growth
+85.4%
Cash Flow
Operating Cash Flow
-$248M
Free Cash Flow
-$294M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$2.3B
Total Liabilities
$1.5B
Stockholders' Equity
$739M
Cash & Equivalents
$510M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$264M
$104M
+152.6%
Gross Profit
$218M
$78M
+178.0%
Operating Income
-$250M
-$230M
-8.4%
Net Income
-$328M
-$236M
-39.5%
Revenue Segments
Reportable Segment
$406M
100%
Geographic Segments
UNITED STATES
$218M
66%
Non-US
$113M
34%
← FY 2025
All Quarters